Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LARGE1 (AA 35-142) Antikörper (PE)

Der Maus Monoklonal Anti--Antikörper wurde für ICFC validiert. Er ist geeignet, in Proben von Human zu detektieren.
Produktnummer ABIN2749158

Kurzübersicht für LARGE1 (AA 35-142) Antikörper (PE) (ABIN2749158)

Target

LARGE1

Reaktivität

  • 4
  • 1
Human

Wirt

  • 3
  • 1
Maus

Klonalität

  • 3
  • 1
Monoklonal

Konjugat

  • 2
  • 2
PE

Applikation

  • 4
  • 3
  • 1
Intracellular Flow Cytometry (ICFC)

Klon

LARGE-02
  • Bindungsspezifität

    AA 35-142

    Verwendungszweck

    Anti-LARGE1 PE

    Spezifität

    The mouse monoclonal antibody LARGE-02 recognizes human LARGE1, a glycosyltransferase expressed mainly in the Golgi apparatus. Crossreactivity with LARGE2 was not determined.

    Kreuzreaktivität (Details)

    Human

    Aufreinigung

    Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

    Immunogen

    Recombinant fragment of human LARGE1 (amino acids 35-142)

    Isotyp

    IgG2b
  • Applikationshinweise

    Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • Target

    LARGE1

    Hintergrund

    LARGE xylosyl- and glucuronyltransferase 1,LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.,Xysosyl- and glucosyl transferase 1

    Gen-ID

    9215

    UniProt

    O95461
Sie sind hier:
Chat with us!